Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION (NDC 7128721901) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 5, 2026 , from http://ppman.hank.ai/transparency/procedure/7128721901/by-state?code_type=NDC
“BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION (NDC 7128721901) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7128721901/by-state?code_type=NDC. Accessed
November 5, 2026 .
“BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION (NDC 7128721901) by State,” HANK Price Transparency ,
accessed November 5, 2026 ,
http://ppman.hank.ai/transparency/procedure/7128721901/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
7128721901 — Brexucabtagene Autoleucel 2x 10exp6 To 2x 10exp8 Cell IV Suspension
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$577,363
National median
$504,081 – $1,612,287
IQR (p25 – p75)
7
hospitals filing
3
states
Walking in without insurance?
Cash / self-pay price
Cash median
$1,732,500
vs. negotiated
+200.1%
Hospitals reporting
7
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7128721901 (NDC), with interquartile range
State Median p25 p75
IL $1,441,440 $1,089,396 $1,581,426
VA $904,624 $57,174 $1,398,797
PA $562,809 $508,862 $1,612,287